Aging liver cells are secretly helping cancer spread — here’s how
Older people are more likely to see their cancer spread to other organs. Researchers now have a molecular explanation: aging liver cells leak tiny packages of genetic material that make tumors elsewhere…
The link between aging and cancer metastasis has long been observed, but poorly understood. A new study published in Nature Aging offers a compelling mechanism — one that puts the liver at the center of the story, not as a direct cancer site, but as an unwitting accomplice.
As liver cells age, they can enter a state called senescence — a kind of permanent standby mode in which cells stop dividing but refuse to die. These senescent cells continuously secrete small membrane-bound particles called extracellular vesicles, loaded with microRNAs: short strands of genetic material that can alter how genes behave in other cells. Normally, the liver uses such signals to regulate processes across the body. But the microRNAs carried by aged liver cells appear to activate tumor cells elsewhere in ways that promote metastasis — the spreading of cancer from its original site.
A broadcast signal for tumors in the bloodstream
In experiments with tumor-bearing aged mice, the researchers tracked extracellular vesicles from senescent liver cells as they traveled through the bloodstream and accumulated near tumors in distant tissues. Once there, the microRNA cargo stimulated processes that help cancer cells detach, migrate, and establish themselves elsewhere — the classic steps of metastatic spread. The team described this as ‘pan-cancer metastasis’, because the effect appeared across multiple cancer types, not just one.
The study gains additional weight from its relevance to human biology. Researchers identified similar molecular patterns in data from older adults with cancer, suggesting the mechanism is not confined to mice. The liver — as the body’s central metabolic hub, constantly broadcasting chemical signals to peripheral tissues — emerges in this model as an age-driven amplifier of cancer’s reach.
Could clearing old cells slow cancer spread?
The findings point toward a new therapeutic angle in oncology. Most cancer treatments focus on the tumor itself. But if the systemic environment shaped by an aging liver is equally important in determining how tumors behave, targeting that environment becomes a legitimate strategy. Senolytic drugs — compounds designed to selectively clear senescent cells — are already being investigated in aging research. Whether they could also reduce metastatic risk in older cancer patients is now a pressing open question.
There are important caveats. Mouse studies don’t always translate cleanly to humans. Which specific microRNAs are responsible, and whether blocking them would disrupt other essential liver functions, remains unknown. The research is early. But the implication is stark: as the liver ages, it may be inadvertently rewriting the rules for how cancer behaves in the same body.